TrumpRx Ties Surface: Recent exchanges highlight how a new government portal for medication discounts draws directly on GoodRx's established pricing network. Observers note that many listed prices align closely with those already available through the platform.
Cuban Connection Discussed: Market watchers continue to reference founder Mark Cuban's role in building the service. Comments emphasize its impact on lowering out-of-pocket costs for consumers without insurance.
Broader Context Emerges: Threads compare the initiative to existing savings tools, underscoring GoodRx's position amid evolving healthcare policy. Participants describe steady interest in its operational reach.
Note: This discussion summary was generated from an AI condensation of post data.
GoodRx Holdings Insider Trading Activity
GoodRx Holdings insiders have traded $GDRX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $GDRX stock by insiders over the last 6 months:
- PARTNERS IV, L.P. FRANCISCO has made 0 purchases and 6 sales selling 1,193,951 shares for an estimated $4,201,230.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
GoodRx Holdings Revenue
GoodRx Holdings had revenues of $200.4M in Q2 2026. This is a decrease of -1.31% from the same period in the prior year.
You can track GDRX financials on Quiver Quantitative's GDRX stock page.
You can access data on GDRX stock through the Quiver Quantitative API.
GoodRx Holdings Hedge Fund Activity
We have seen 70 institutional investors add shares of GoodRx Holdings stock to their portfolio, and 108 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANE STREET GROUP, LLC added 1,665,363 shares (+257.1%) to their portfolio in Q2 2026, for an estimated $4,796,245
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM added 1,108,766 shares (+192.6%) to their portfolio in Q2 2026, for an estimated $3,193,246
- MOORE CAPITAL MANAGEMENT, LP removed 665,371 shares (-43.5%) from their portfolio in Q2 2026, for an estimated $1,916,268
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 660,133 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $1,901,183
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 553,844 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,595,070
- TWO SIGMA INVESTMENTS, LP added 553,810 shares (+294.0%) to their portfolio in Q2 2026, for an estimated $1,594,972
- MARSHALL WACE, LLP added 543,028 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,563,920
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
GoodRx Holdings Price Targets
Multiple analysts have issued price targets for $GDRX recently. We have seen 5 analysts offer price targets for $GDRX in the last 6 months, with a median target of $3.5.
Here are some recent targets:
- Daniel Grosslight from Citigroup set a target price of $4.0 on 05/14/2026
- Charles Rhyee from TD Cowen set a target price of $4.0 on 05/11/2026
- Stan Berenshteyn from Wells Fargo set a target price of $3.5 on 03/04/2026
- Eric Sheridan from Goldman Sachs set a target price of $2.5 on 03/02/2026
- Steven Valiquette from Mizuho set a target price of $3.0 on 02/27/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
